Key result
Untreated thyrotoxicosis is linked to ~29% lower central arterial stiffness, which increases after radioiodine treatment.
Why the study?
The effect of thyrotoxicosis and its treatment on central arterial stiffness was not well characterized.
Does thyrotoxicosis and its treatment with radioiodine affect central arterial stiffness?
Case-Control (n=40)
Does thyrotoxicosis and its treatment with radioiodine affect central arterial stiffness?
Untreated thyrotoxicosis is associated with decreased central arterial stiffness, which normalizes after radioiodine treatment, suggesting thyrotoxicosis does not increase cardiovascular risk via arterial stiffening.
Answers are grounded in this paper and cite their sources.
Should not alter thyrotoxicosis management; leaves open whether stiffness changes affect cardiovascular outcomes.
OBJECTIVE: To assess central arterial stiffness in thyrotoxicosis using the technique of pulse wave analysis. DESIGN: Case control study designed to determine the effect of thyrotoxicosis on central arterial stiffness and at 6 months after radioiodine treatment. PATIENTS: Twenty (18 women and 2 men) thyrotoxic patients and 20 age- and sex-matched controls were studied at baseline. Thyrotoxic patients were re-studied at 6 months following treatment of thyrotoxicosis with 555 MBq (131)I with no additional therapy for the six-month period. MEASUREMENTS: Using the sphygmocor apparatus, peripheral pressure waveforms were recorded non-invasively from the radial artery and central pressure waveforms were generated from these. Indices of arterial stiffness, central augmentation index (AI), augmentation of central arterial pressure (AG) and central blood pressures were derived. AI corrected for heart rate (AIc) was calculated. RESULTS: Thyrotoxic patients recorded a significantly lower AI (means+/-s.e.m.) compared with controls (15.0+/-2.1 vs 28.0+/-2.1%; P<0.0005) even when corrected for differences in heart rate AIc (20.0+/-2.1 vs 28.0+/-2.1%; P<0.005) as well as AG (6.0+/-0.8 vs 10.0+/-1.1 mmHg; P<0.002) but higher pulse pressure (58.0+/-3.5 vs 47.0+/-2.0 mmHg; P<0.02). At 6 months following treatment, a significant rise in AIc (27.0+/-1.8 vs 20.0+/-2.1%; P<0.005) and AG (11.0+/-1.0 vs 6.0+/-0.8 mmHg; P<0.005) was noted. Lipid profiles were comparable between the groups. CONCLUSIONS: These data suggested that subjects with untreated thyrotoxicosis have a decreased augmentation of central arterial pressure or lowered central arterial stiffness that would not appear to contribute to any excess cardiovascular risk in that condition.
No takes yet. Share an insight, caveat, or question.
Obuobie et al. (2002) conducted a case-control in Thyrotoxicosis (n=40). Thyrotoxicosis vs. Age- and sex-matched controls was evaluated on Central augmentation index corrected for heart rate (AIc) (p=<0.005). Untreated thyrotoxicosis was associated with lower central arterial stiffness compared to controls, which increased 6 months after radioiodine treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: